Does the effect of cognitive behavior therapy for chronic fatigue syndrome (ME/CFS) vary by patient characteristics? A systematic review and individual patient data meta-analysis.
Kuut, T A, Buffart, L M, Braamse, A M J et al. · Psychological medicine · 2024 · DOI
Quick Summary
This study combined data from 8 clinical trials involving 1,298 people with ME/CFS to see whether cognitive behavior therapy (CBT) works and who benefits most from it. Researchers found that CBT did help reduce fatigue, improve daily functioning, and increase physical activity—but the amount of benefit varied depending on patient characteristics like age, how much disability someone had, and their activity patterns. Younger patients, those with less severe disability at the start, and those with fluctuating activity patterns saw the most improvement.
Why It Matters
This analysis provides the largest systematic evidence to date on CBT's effectiveness for ME/CFS and identifies which patients are most likely to benefit. Understanding treatment response variation can help clinicians better counsel patients on realistic expectations and tailor treatment approaches. The findings challenge recent guideline recommendations that downgraded evidence from studies not requiring post-exertional malaise criteria.
Observed Findings
- CBT significantly reduced fatigue severity (mean reduction ~11.46 points on standardized scale) across pooled trials
- Functional impairment decreased substantially (~448 points on SIP-8) in CBT-treated patients compared to controls
- Physical functioning improved by approximately 9.64 points on Short Form-36 subscale
- Younger patients showed greater fatigue reduction than older patients in response to CBT
- Patients with fluctuating (rather than consistently low or high) activity patterns at baseline benefitted more from treatment
Inferred Conclusions
- CBT can produce clinically meaningful reductions in fatigue, functional impairment, and physical limitations in ME/CFS populations
- Treatment response is moderated by patient characteristics including age, baseline functional status, activity pattern, and self-efficacy beliefs
- PEM status and the presence of additional symptoms do not predict poorer CBT outcomes, suggesting CBT benefits are not limited to specific case definitions
- Clinicians may improve patient selection and outcome prediction by considering baseline age, disability severity, and activity patterns when recommending CBT
Remaining Questions
- What biological or psychological mechanisms explain why younger patients and those with higher self-efficacy respond better to CBT?
- Do the identified moderators predict response in diverse healthcare settings outside controlled research trials?
- How do long-term outcomes differ based on the moderator characteristics identified in this analysis?
- Why does presence or absence of PEM not moderate CBT response, and what does this reveal about ME/CFS pathophysiology?
What This Study Does Not Prove
This study does not prove CBT is a cure for ME/CFS or that it works equally well for all patients. It cannot establish causation regarding why certain characteristics predict better outcomes—the mechanisms remain unclear. The pooled trials may not represent all ME/CFS populations, and benefits measured in controlled settings may not fully translate to real-world clinical practice.
Topics
Tags
Metadata
- DOI
- 10.1017/S0033291723003148
- PMID
- 37927223
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 7 April 2026